|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 349 EUR | +0.72% |
|
-7.18% | -2.92% |
| Apr. 17 | VIRBAC : A healthy start to 2024; outlook re-iterated |  |
| Apr. 17 | Virbac: sales up by almost 10% in Q1 | CF |
Virbac SA provided earnings guidance for the year 2024. For the year, the company expects at constant exchange rates and scope, expect a ratio of ?current operating income before depreciation of assets resulting from acquisitions? (Ebit adjusted) to ?revenue?
around 15% with growth in revenue estimated at this stage to be between 4% and 6%.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.92% | 3.12B | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -0.68% | 1.4B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -14.67% | 1.12B | |
| -5.37% | 990M | |
| -24.06% | 805M |
VIRBAC 
